(MONT) Montea C.V.A. - Ratings and Ratios
Warehouses, Logistics, Distribution, Hubs
MONT EPS (Earnings per Share)
MONT Revenue
Description: MONT Montea C.V.A.
Montea C.V.A. is a Belgian Industrial REIT listed on the Euronext Brussels stock exchange under the ticker symbol MONT. As a Real Estate Investment Trust, the companys primary business is owning and managing industrial properties, generating revenue through rental income.
The companys market capitalization stands at approximately €1.5 billion, with a relatively low Price-to-Earnings (P/E) ratio of 8.07, suggesting potential undervaluation. The forward P/E ratio is higher at 12.72, indicating expected growth in earnings. Monteas Return on Equity (RoE) is 12.22%, demonstrating a decent level of profitability.
Key economic drivers for Montea include the overall demand for industrial space, driven by the growth of e-commerce and logistics. The companys performance is also influenced by the Belgian and European real estate market conditions, including rental yields, occupancy rates, and property valuations. Important KPIs to monitor include Net Asset Value (NAV) per share, rental income growth, and the loan-to-value (LTV) ratio, which can indicate the companys level of indebtedness and financial flexibility.
To further evaluate Monteas investment potential, it is essential to analyze its portfolio composition, including the quality and diversification of its properties, as well as its tenant profile and lease expirations. Additionally, monitoring the companys debt profile, including interest rates and maturity profiles, can provide insights into its financial stability and ability to meet its obligations.
MONT Stock Overview
| Market Cap in USD | 1,852m |
| Sub-Industry | Industrial REITs |
| IPO / Inception |
MONT Stock Ratings
| Growth Rating | -23.6% |
| Fundamental | 63.1% |
| Dividend Rating | 64.2% |
| Return 12m vs S&P 500 | -22.1% |
| Analyst Rating | - |
MONT Dividends
| Dividend Yield 12m | 3.97% |
| Yield on Cost 5y | 3.08% |
| Annual Growth 5y | 8.04% |
| Payout Consistency | 88.2% |
| Payout Ratio | 80.8% |
MONT Growth Ratios
| Growth Correlation 3m | 84.1% |
| Growth Correlation 12m | -0.1% |
| Growth Correlation 5y | -68.3% |
| CAGR 5y | -4.23% |
| CAGR/Max DD 5y | -0.08 |
| Sharpe Ratio 12m | -0.18 |
| Alpha | -13.33 |
| Beta | 0.201 |
| Volatility | 21.46% |
| Current Volume | 23.4k |
| Average Volume 20d | 25.5k |
| Stop Loss | 66.2 (-3.1%) |
| Signal | -0.96 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (208.7m TTM) > 0 and > 6% of Revenue (6% = 10.3m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -2.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -17.52% (prev -23.31%; Δ 5.79pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 144.1m <= Net Income 208.7m (YES >=105%, WARN >=100%) |
| Net Debt (1.08b) to EBITDA (174.1m) ratio: 6.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.0m) change vs 12m ago 14.34% (target <= -2.0% for YES) |
| Gross Margin 86.61% (prev 83.50%; Δ 3.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.25% (prev 5.30%; Δ 0.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.33 (EBITDA TTM 174.1m / Interest Expense TTM 18.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.16
| (A) -0.01 = (Total Current Assets 65.3m - Total Current Liabilities 95.4m) / Total Assets 3.02b |
| (B) 0.06 = Retained Earnings (Balance) 171.5m / Total Assets 3.02b |
| (C) 0.06 = EBIT TTM 173.6m / Avg Total Assets 2.75b |
| (D) 1.54 = Book Value of Equity 1.84b / Total Liabilities 1.19b |
| Total Rating: 2.16 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.12
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 5.16% = 2.58 |
| 3. FCF Margin 82.97% = 7.50 |
| 4. Debt/Equity 0.65 = 2.30 |
| 5. Debt/Ebitda 6.83 = -2.50 |
| 6. ROIC - WACC 3.17% = 3.96 |
| 7. RoE 12.22% = 1.02 |
| 8. Rev. Trend 36.98% = 1.85 |
| 9. Rev. CAGR 5.13% = 0.64 |
| 10. EPS Trend 10.95% = 0.27 |
| 11. EPS CAGR -38.51% = -2.50 |
What is the price of MONT shares?
Over the past week, the price has changed by -2.43%, over one month by +4.12%, over three months by +4.27% and over the past year by -8.93%.
Is Montea C.V.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MONT is around 67.32 EUR . This means that MONT is currently overvalued and has a potential downside of -1.43%.
Is MONT a buy, sell or hold?
What are the forecasts/targets for the MONT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78.8 | 15.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 72.4 | 6% |
MONT Fundamental Data Overview
Market Cap EUR = 1.59b (1.59b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 15.1m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 8.5414
P/E Forward = 13.587
P/S = 11.1053
P/B = 0.8738
Beta = 0.699
Revenue TTM = 172.0m EUR
EBIT TTM = 173.6m EUR
EBITDA TTM = 174.1m EUR
Long Term Debt = 1.09b EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 95.4m EUR (from totalCurrentLiabilities, last quarter)
Debt = 1.19b EUR (Calculated: Short Term 95.4m + Long Term 1.09b)
Net Debt = 1.08b EUR (from netDebt column, last quarter)
Enterprise Value = 2.76b EUR (1.59b + Debt 1.19b - CCE 15.1m)
Interest Coverage Ratio = 9.33 (Ebit TTM 173.6m / Interest Expense TTM 18.6m)
FCF Yield = 5.16% (FCF TTM 142.7m / Enterprise Value 2.76b)
FCF Margin = 82.97% (FCF TTM 142.7m / Revenue TTM 172.0m)
Net Margin = 121.4% (Net Income TTM 208.7m / Revenue TTM 172.0m)
Gross Margin = 86.61% ((Revenue TTM 172.0m - Cost of Revenue TTM 23.0m) / Revenue TTM)
Tobins Q-Ratio = 1.51 (Enterprise Value 2.76b / Book Value Of Equity 1.84b)
Interest Expense / Debt = 1.57% (Interest Expense 18.6m / Debt 1.19b)
Taxrate = 4.08% (from yearly Income Tax Expense: 7.29m / 178.8m)
NOPAT = 166.6m (EBIT 173.6m * (1 - 4.08%))
Current Ratio = 0.68 (Total Current Assets 65.3m / Total Current Liabilities 95.4m)
Debt / Equity = 0.65 (Debt 1.19b / last Quarter total Stockholder Equity 1.84b)
Debt / EBITDA = 6.83 (Net Debt 1.08b / EBITDA 174.1m)
Debt / FCF = 8.33 (Debt 1.19b / FCF TTM 142.7m)
Total Stockholder Equity = 1.71b (last 4 quarters mean)
RoA = 6.90% (Net Income 208.7m, Total Assets 3.02b )
RoE = 12.22% (Net Income TTM 208.7m / Total Stockholder Equity 1.71b)
RoCE = 6.20% (Ebit 173.6m / (Equity 1.71b + L.T.Debt 1.09b))
RoIC = 7.68% (NOPAT 166.6m / Invested Capital 2.17b)
WACC = 4.51% (E(1.59b)/V(2.78b) * Re(6.76%)) + (D(1.19b)/V(2.78b) * Rd(1.57%) * (1-Tc(0.04)))
Shares Correlation 5-Years: 100.0 | Cagr: 9.47%
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 74.59% ; FCFE base≈160.6m ; Y1≈128.6m ; Y5≈87.5m
Fair Price DCF = 70.61 (DCF Value 1.62b / Shares Outstanding 23.0m; 5y FCF grow -23.84% → 3.0% )
Revenue Correlation: 36.98 | Revenue CAGR: 5.13%
Rev Growth-of-Growth: -0.01
EPS Correlation: 10.95 | EPS CAGR: -38.51%
EPS Growth-of-Growth: -6.26